Departments of EndocrinologyDiabetes and Nutrition.
Departments of RadiologyCHU Haut-Leveque and University of Bordeaux, Bordeaux, France.
Eur J Endocrinol. 2018 May;178(5):439-446. doi: 10.1530/EJE-17-1056. Epub 2018 Feb 21.
The recent recommendations of the European Endocrine Society states that the performance of computed tomography (CT) to characterize 'true' adrenal incidentalomas (AIs) remains debatable.
To determine relevant thresholds for usual CT parameters for the diagnosis of benign tumors using robust reference standard among a large series of 'true' AIs recruited in an endocrinological setting.
Retrospective study of 253 AIs in 233 consecutive patients explored in a single university hospital: 183 adenomas, 33 pheochromocytomas, 23 adrenocortical carcinomas, 5 other malignant tumors and 9 other benign tumors. Reference standard was histopathology in 118 AIs, biological diagnosis of pheochromocytoma in 2 AIs and size stability after at least 1 year of follow-up in 133 AIs.
Sensitivity, specificity and positive and negative predictive values were estimated for various thresholds of size, unenhanced attenuation (UA), relative and absolute wash-out (RPW, APW) of contrast media. 197 scans were reviewed independently in a blinded fashion by two expert radiologists to assess inter-observer reproducibility of measurements.
Criteria associated with a 100% positive predictive value for the diagnosis of benign AI were: a combination of size and UA: 30 mm and 20 HU or 40 mm and 15 HU, respectively; RPW >53%; and APW >78%. Non-adenomatous AIs with rapid contrast wash-out were exclusively benign pseudocysts and pheochromocytomas, suggesting that classical thresholds of 60% and 40% for APW and RPW, respectively, can be safely used for patients with normal metanephrine values. Inter-observer reproducibility of all parameters was excellent (intra-class correlation coefficients: 0.96-0.99).
Our study, the largest conducted in AIs recruited in an endocrinological setting, suggests safe thresholds for quantitative CT parameters to avoid false diagnoses of benignity.
最近欧洲内分泌学会的建议指出,使用计算机断层扫描(CT)来描述“真正的”肾上腺偶发瘤(AIs)的性能仍存在争议。
使用大量在内分泌环境中招募的“真正的”AIs 系列中稳健的参考标准,确定用于诊断良性肿瘤的常用 CT 参数的相关阈值。
在一家大学医院对 233 例连续患者的 253 例 AIs 进行回顾性研究:183 例腺瘤、33 例嗜铬细胞瘤、23 例肾上腺皮质癌、5 例其他恶性肿瘤和 9 例其他良性肿瘤。118 例 AIs 的参考标准为组织病理学,2 例嗜铬细胞瘤的生物学诊断,133 例 AIs 的大小稳定至少 1 年的随访。
为各种大小、未增强衰减(UA)、对比剂相对和绝对洗脱(RPW、APW)的阈值估计了敏感性、特异性和阳性及阴性预测值。2 名专家放射科医生独立对 197 次扫描进行了盲法回顾,以评估测量的观察者间可重复性。
与良性 AI 诊断的 100%阳性预测值相关的标准是:大小和 UA 的组合:分别为 30mm 和 20HU 或 40mm 和 15HU;RPW>53%;APW>78%。具有快速对比洗脱的非腺瘤性 AIs 仅为良性假性囊肿和嗜铬细胞瘤,这表明对于正常间甲肾上腺素值的患者,APW 和 RPW 的经典阈值分别为 60%和 40%可以安全使用。所有参数的观察者间可重复性均极佳(组内相关系数:0.96-0.99)。
我们的研究是在内分泌环境中招募的 AIs 中进行的最大规模研究,表明了定量 CT 参数的安全阈值,可以避免良性肿瘤的误诊。